Poehling Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $226K | Sell |
|
|||||
|
2025
Q1 | $222K | Sell |
|
|||||
|
2024
Q4 | $255K | Buy |
|
|||||
|
2024
Q3 | $273K | Sell |
|
|||||
|
2024
Q2 | $276K | Sell |
|
|||||
|
2024
Q1 | $283K | Sell |
|
|||||
|
2023
Q4 | $268K | Sell |
|
|||||
|
2023
Q3 | $219K | Sell |
|
|||||
|
2023
Q2 | $255K | Hold |
|
|||||
|
2023
Q1 | $234K | Sell |
|
|||||
|
2022
Q4 | $255K | Sell |
|
|||||
|
2022
Q3 | $283K | Sell |
|
|||||
|
2022
Q2 | $266K | Sell |
|
|||||
|
2022
Q1 | $911K | Buy |
|
|||||
|
2021
Q4 | $526K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $7K | Hold |
|
|||||
|
2018
Q1 | $7K | Hold |
|
|||||
|
2017
Q4 | $6K | Buy |
|